Vivos (RDGL) Operating Income (2010 - 2025)
Vivos' (RDGL) quarterly Operating Income came in at -$1.1 million in Q4 2025, down 65.57% year-on-year from -$3.2 million in Q4 2024, and down 106.34% quarter-over-quarter from -$531023.0 in Q3 2025.
Vivos (RDGL) Operating Income (2010 - 2025) Analysis & Trends
Vivos has disclosed Operating Income across 16 years of filings, most recently posting -$1.1 million for Q4 2025.
- Operating Income for Q4 2025 came in at -$1.1 million, down 65.57% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.2 million (down 21.53% YoY), and the FY2025 annual result was -$3.2 million, down 21.53% from the prior year.
- Operating Income came in at -$1.1 million for Q4 2025 at Vivos, down from -$531023.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$194583.0 in Q3 2021 to a low of -$1.9 million in Q2 2021.
- The 5-year median for Operating Income is -$681202.5 (2023), against an average of -$679106.2.
- Across the five-year window, Operating Income tumbled 1343.08% in 2021 and surged 66.78% in 2023, its largest moves.
- Vivos' Operating Income stood at -$218440.0 in 2021, then plunged by 223.04% to -$705653.0 in 2022, then tumbled by 33.61% to -$942791.0 in 2023, then increased by 29.8% to -$661800.0 in 2024, then tumbled by 65.57% to -$1.1 million in 2025.
- The last three Operating Income figures came in at -$1.1 million (Q4 2025), -$531023.0 (Q3 2025), and -$674772.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 477.60 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 515.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 255.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Vivos | - | - | -3,105.00 | -1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.10 Mn |
| Sep 30, 2025 | -531,023.00 |
| Jun 30, 2025 | -674,772.00 |
| Mar 31, 2025 | -863,532.00 |
| Dec 31, 2024 | -661,800.00 |
| Sep 30, 2024 | -843,145.00 |
| Jun 30, 2024 | -522,309.00 |
| Mar 31, 2024 | -577,129.00 |
| Dec 31, 2023 | -942,791.00 |
| Sep 30, 2023 | -687,633.00 |
| Jun 30, 2023 | -914,405.00 |
| Mar 31, 2023 | -248,318.00 |
| Dec 31, 2022 | -705,653.00 |
| Sep 30, 2022 | -277,065.00 |
| Jun 30, 2022 | -787,538.00 |
| Mar 31, 2022 | -747,493.00 |
| Dec 31, 2021 | -218,440.00 |
| Sep 30, 2021 | -194,583.00 |
| Jun 30, 2021 | -1.85 Mn |
| Mar 31, 2021 | -235,090.00 |